Arama Sonuçları - Philip S. Watson

Sonuçları Daraltın
  1. 1
    Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer

    Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer Yazar: Philip A. Watson, Vivek Arora, Charles L. Sawyers

    Baskı/Yayın Bilgisi 2015
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  2. 2
    Androgen Receptor Signaling in Salivary Gland Cancer

    Androgen Receptor Signaling in Salivary Gland Cancer Yazar: Martin G. Dalin, Philip A. Watson, Alan L. Ho, Luc G.T. Morris

    Baskı/Yayın Bilgisi 2017
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  3. 3
    Mutations of the<i>PDS</i>Gene, Encoding Pendrin, Are Associated with Protein Mislocalization and Loss of Iodide Efflux: Implications for Thyroid Dysfunction in Pendred Syndrome

    Mutations of the<i>PDS</i>Gene, Encoding Pendrin, Are Associated with Protein Mislocalization and Loss of Iodide Efflux: Implications for Thyroid Dysfunction in Pendred Syndrome Yazar: Julie P. Taylor, Russell Metcalfe, Philip F. Watson, Anthony P. Weetman, Richard C. Trembath

    Baskı/Yayın Bilgisi 2002
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  4. 4
    The Calcium-Sensing Receptor Is a Target of Autoantibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1

    The Calcium-Sensing Receptor Is a Target of Autoantibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1 Yazar: Nikos Gavalas, E. Helen Kemp, Kai Krohn, Edward M. Brown, Philip F. Watson, Anthony P. Weetman

    Baskı/Yayın Bilgisi 2007
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  5. 5
    Activating Autoantibodies against the Calcium-Sensing Receptor Detected in Two Patients with Autoimmune Polyendocrine Syndrome Type 1

    Activating Autoantibodies against the Calcium-Sensing Receptor Detected in Two Patients with Autoimmune Polyendocrine Syndrome Type 1 Yazar: E. Helen Kemp, Nikos Gavalas, Kai Krohn, Edward M. Brown, Philip F. Watson, Anthony P. Weetman

    Baskı/Yayın Bilgisi 2009
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  6. 6
    Murine Cell Lines Derived from <i>Pten</i> Null Prostate Cancer Show the Critical Role of PTEN in Hormone Refractory Prostate Cancer Development

    Murine Cell Lines Derived from <i>Pten</i> Null Prostate Cancer Show the Critical Role of PTEN in Hormone Refractory Prostate Cancer Development Yazar: Jing Jiao, Shunyou Wang, Rong Qiao, Igor Vivanco, Philip A. Watson, Charles L. Sawyers, Hong Wu

    Baskı/Yayın Bilgisi 2007
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  7. 7
    A shift in the Bax/Bcl-2 balance may activate caspase-3 and modulate apoptosis in experimental glomerulonephritis

    A shift in the Bax/Bcl-2 balance may activate caspase-3 and modulate apoptosis in experimental glomerulonephritis Yazar: Bin Yang, Timothy S. Johnson, Graham L. Thomas, Philip F. Watson, Bart Wagner, Peter Furness, A. Meguid El Nahas

    Baskı/Yayın Bilgisi 2002
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  8. 8
    Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor

    Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor Yazar: Philip A. Watson, Yinan F. Chen, Minna Balbas, John Wongvipat, Nicholas D. Socci, Agnès Viale, Kwanghee Kim, Charles L. Sawyers

    Baskı/Yayın Bilgisi 2010
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  9. 9
    Overcoming mutation-based resistance to antiandrogens with rational drug design

    Overcoming mutation-based resistance to antiandrogens with rational drug design Yazar: Minna Balbas, Michael J. Evans, David J. Hosfield, John Wongvipat, Vivek Arora, Philip A. Watson, Yu Chen, Geoffrey L. Greene, Yang Shen, Charles L. Sawyers

    Baskı/Yayın Bilgisi 2013
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  10. 10
    The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo

    The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo Yazar: E. Helen Kemp, Elizabeth A. Waterman, Brian E. Hawes, Kim O’Neill, Raju V.S.R.K. Gottumukkala, David J. Gawkrodger, Anthony P. Weetman, Philip F. Watson

    Baskı/Yayın Bilgisi 2002
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  11. 11
    The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo

    The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo Yazar: E. Helen Kemp, Elizabeth A. Waterman, Brian E. Hawes, Kim O’Neill, Raju V.S.R.K. Gottumukkala, David J. Gawkrodger, Anthony P. Weetman, Philip F. Watson

    Baskı/Yayın Bilgisi 2002
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  12. 12
    FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes

    FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes Yazar: Elizabeth Adams, Wouter R. Karthaus, Elizabeth Hoover, Deli Liu, Antoine Gruet, Zeda Zhang, Hyunwoo Cho, Rose DiLoreto, Sagar Chhangawala, Yang Liu, Philip A. Watson, Elai Davicioni, Andrea Sboner, Christopher E. Barbieri, Rohit Bose, Christina Leslie, Charles L. Sawyers

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  13. 13
    Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer

    Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer Yazar: Chris Tran, Samedy Ouk, Nicola J. Clegg, Yu Chen, Philip A. Watson, Vivek Arora, John Wongvipat, Peter Smith‐Jones, Dongwon Yoo, Andrew Kwon, Teresa Wasielewska, Derek S. Welsbie, Charlie Degui Chen, Celestia S. Higano, Tomasz M. Beer, David T. Hung, Howard I. Scher, Michael E. Jung, Charles L. Sawyers

    Baskı/Yayın Bilgisi 2009
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  14. 14
    Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer

    Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer Yazar: Michael R. McDevitt, Daniel L.J. Thorek, Takeshi Hashimoto, Tatsuo Gondo, Darren R. Veach, Sai Kiran Sharma, Teja Kalidindi, Diane S. Abou, Philip A. Watson, Bradley J. Beattie, Oskar Vilhemsson Timmermand, Sven‐Erik Strand, Jason S. Lewis, Peter T. Scardino, Howard I. Scher, Hans Lilja, Steven M. Larson, David Ulmert

    Baskı/Yayın Bilgisi 2018
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  15. 15
    Allosteric interactions prime androgen receptor dimerization and activation

    Allosteric interactions prime androgen receptor dimerization and activation Yazar: Elizabeth V. Wasmuth, Arnaud Vanden Broeck, Justin LaClair, Elizabeth A. Hoover, Kayla E. Lawrence, Navid Paknejad, Kyrie Pappas, Doreen Matthies, Biran Wang, Weiran Feng, Philip A. Watson, John C. Zinder, Wouter R. Karthaus, M. Jason de la Cruz, Richard K. Hite, Katia Manova‐Todorova, Zhiheng Yu, Susan T. Weintraub, Sebastian Klinge, Charles L. Sawyers

    Baskı/Yayın Bilgisi 2022
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  16. 16
    <i>SOX2</i> promotes lineage plasticity and antiandrogen resistance in <i>TP53</i> - and <i>RB1</i> -deficient prostate cancer

    <i>SOX2</i> promotes lineage plasticity and antiandrogen resistance in <i>TP53</i> - and <i>RB1</i> -deficient prostate cancer Yazar: Ping Mu, Zeda Zhang, Matteo Benelli, Wouter R. Karthaus, Elizabeth Hoover, Chi-Chao Chen, John Wongvipat, Sheng‐Yu Ku, Dong Gao, Zhen Cao, Neel Shah, Elizabeth Adams, Wassim Abida, Philip A. Watson, Davide Prandi, Chun‐Hao Huang, Elisa de Stanchina, Scott W. Lowe, Leigh Ellis, Himisha Beltran, Mark A. Rubin, David W. Goodrich, Francesca Demichelis, Charles L. Sawyers

    Baskı/Yayın Bilgisi 2017
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  17. 17
    Androgen Receptor Signaling Regulates DNA Repair in Prostate Cancers

    Androgen Receptor Signaling Regulates DNA Repair in Prostate Cancers Yazar: William R. Polkinghorn, Joel S. Parker, Man X. Lee, Elizabeth M. Kass, Daniel E. Spratt, Phillip J. Iaquinta, Vivek Arora, Wei-Feng Yen, Ling Cai, Deyou Zheng, Brett S. Carver, Yu Chen, Philip A. Watson, Neel Shah, Sho Fujisawa, Alexander G. Goglia, Anuradha Gopalan, Haley Hieronymus, John Wongvipat, Peter T. Scardino, Michael J. Zeléfsky, Maria Jasin, Jayanta Chaudhuri, Simon N. Powell, Charles L. Sawyers

    Baskı/Yayın Bilgisi 2013
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  18. 18
    Somatic Tissue Engineering in Mouse Models Reveals an Actionable Role for WNT Pathway Alterations in Prostate Cancer Metastasis

    Somatic Tissue Engineering in Mouse Models Reveals an Actionable Role for WNT Pathway Alterations in Prostate Cancer Metastasis Yazar: Josef Leibold, Marcus Ruscetti, Zhen Cao, Yu-Jui Ho, Timour Baslan, Min Zou, Wassim Abida, Judith Feucht, Teng Han, Francisco M. Barriga, Kaloyan M. Tsanov, Leah Zamechek, Amanda Kulick, Corina Amor, Sha Tian, Katarzyna Rybczyk, Nelson R. Salgado, Francisco J. Sánchez‐Rivera, Philip A. Watson, Elisa de Stanchina, John E. Wilkinson, Lukas E. Dow, Cory Abate‐Shen, Charles L. Sawyers, Scott W. Lowe

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  19. 19
    Genetic Meningococcal Antigen Typing System (gMATS): A genotyping tool that predicts 4CMenB strain coverage worldwide

    Genetic Meningococcal Antigen Typing System (gMATS): A genotyping tool that predicts 4CMenB strain coverage worldwide Yazar: Alessandro Muzzi, Alessandro Brozzi, Laura Serino, Margherita Bodini, Raquel Abad, Dominique A. Caugant, Maurizio Comanducci, Ana Paula Silva de Lemos, Maria Cecília Gorla, Pavla Křížová, Claudia Mikula, Robert Mulhall, Michael D. Nissen, Hanna Nohynek, Maria João Simões, Anna Skoczyńska, Paola Stefanelli, Muhamed‐Kheir Taha, Maija Toropainen, Georgina Tzanakaki, Kumaran Vadivelu-Pechai, Philip S. Watson, Julio A. Vázquez, Gowrisankar Rajam, Rino Rappuoli, Ray Borrow, Duccio Medini

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  20. 20
    Targeting prostate tumor low–molecular weight tyrosine phosphatase for oxidation-sensitizing therapy

    Targeting prostate tumor low–molecular weight tyrosine phosphatase for oxidation-sensitizing therapy Yazar: Stephanie M. Stanford, Tiffany P. Nguyen, Joseph T. Chang, Zixuan Zhao, G. Lavender Hackman, Eugenio Santelli, Colton M. Sanders, Madhusudhanarao Katiki, Eleonora Dondossola, Brooke L. Brauer, Michael A. Diaz, Yuan Zhan, Sterling H. Ramsey, Philip A. Watson, Banumathi Sankaran, Claudia Paindelli, Vanessa Parietti, Antonios G. Mikos, Alessia Lodi, Aditya Bagrodia, Andrew Elliott, Rana R. McKay, Ramachandran Murali, Stefano Tiziani, Arminja N. Kettenbach, Nunzio Bottini

    Baskı/Yayın Bilgisi 2024
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:

Arama Araçları: